Home/Filings/4/0001212655-04-000001
4//SEC Filing

ATRIX LABORATORIES INC 4

Accession 0001212655-04-000001

CIK 0000809875operating

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 12:47 PM ET

Size

9.0 KB

Accession

0001212655-04-000001

Insider Transaction Report

Form 4
Period: 2004-04-05
BETHUNE DAVID R
DirectorCEO/Chairman
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (Right-To-Buy)

    2004-04-05$6.88/sh+10,000$68,800156,477 total
  • Sale

    Non-Qualified Stock Option (Right-To-Buy)

    2004-04-05$26.34/sh10,000$263,410146,477 total
Footnotes (1)
  • [F1]The non-qualified stock option exercise and subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the beneficial owner.

Issuer

ATRIX LABORATORIES INC

CIK 0000809875

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000809875

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 12:47 PM ET
Size
9.0 KB